Understanding how testican-2 affects kidney cell health
Biological function of testican-2 in podocyte health
This study is looking at a protein called testican-2 that comes from kidney cells to see how it helps keep important kidney cells called podocytes healthy, which is really important for how well your kidneys filter blood, especially for people with kidney disease.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11083587 on NIH RePORTER |
What this research studies
This research investigates the role of testican-2, a protein released by kidney cells, in maintaining the health of podocytes, which are crucial for kidney function. By analyzing samples from human subjects, the study aims to understand how testican-2 interacts with other proteins and influences kidney health, particularly in relation to kidney filtration rates. The research will explore how testican-2 can protect podocytes from injury and its potential mechanisms of action. Through a series of experiments, the researchers will assess the effects of testican-2 on podocyte function and its implications for kidney disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with kidney conditions or those at risk of kidney disease, particularly those with altered levels of testican-2.
Not a fit: Patients with no kidney issues or those who do not have measurable levels of testican-2 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and therapeutic strategies for protecting kidney function in patients with kidney disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of proteins like testican-2 in kidney health, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Wen, Donghai — Massachusetts General Hospital
- Study coordinator: Wen, Donghai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.